Clinical trialNCT00026403CompletedPhase 2Interventional

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic Cancer

SponsorAlliance for Clinical Trials in OncologyEnrollment48Pancreatic Cancer

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining radiation therapy with chemotherapy may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy plus radiation therapy in treating patients who have locally advanced pancreatic cancer.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Michael G. Haddock, MD
Mayo Clinic
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada

Allan Blair Cancer Centre
Regina, Saskatchewan, Canada

United States

Ccop - Scottsdale Oncology Program
Scottsdale, Arizona, United States
Mbccop - Howard University Cancer Center
Washington D.C., District of Columbia, United States
Ccop - Illinois Oncology Research Association
Peoria, Illinois, United States
Methodist Medical Center of Illinois
Peoria, Illinois, United States
Ccop - Carle Cancer Center
Urbana, Illinois, United States
Ccop - Cedar Rapids Oncology Project
Cedar Rapids, Iowa, United States
Ccop - Iowa Oncology Research Association
Des Moines, Iowa, United States
Siouxland Hematology-Oncology
Sioux City, Iowa, United States
Ccop - Wichita
Wichita, Kansas, United States
Ccop - Ochsner
New Orleans, Louisiana, United States
Ccop - Michigan Cancer Research Consortium
Ann Arbor, Michigan, United States
Ccop - Duluth
Duluth, Minnesota, United States
Mayo Clinic Cancer Center
Rochester, Minnesota, United States
Centracare Health Plaza
Saint Cloud, Minnesota, United States
Ccop - Metro-Minnesota
Saint Louis Park, Minnesota, United States
Ccop - Missouri Valley Cancer Consortium
Omaha, Nebraska, United States
Medcenter One Health System
Bismarck, North Dakota, United States
Ccop - Merit Care Hospital
Fargo, North Dakota, United States
Altru Cancer Center
Grand Forks, North Dakota, United States
Ccop - Toledo Community Hospital
Toledo, Ohio, United States
Ccop - Geisinger Clinic and Medical Center
Danville, Pennsylvania, United States
Allegheny General Hospital
Pittsburgh, Pennsylvania, United States
Rapid City Regional Hospital
Rapid City, South Dakota, United States
Ccop - Sioux Community Cancer Consortium
Sioux Falls, South Dakota, United States
Ccop - St. Vincent Hospital Cancer Center, Green Bay
Green Bay, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Cisplatin →Gemcitabine →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Sept 2001
Primary completion: 30 Jun 2007
Completion: 31 Jul 2009
Last update posted: 14 Jul 2016
Registered enrollment: 48
Registry id: NCT00026403

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.